首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >Propensity Score Weighting Using Overlap Weights: A New Method Applied to Regorafenib Clinical Data and a Cost-Effectiveness Analysis
【24h】

Propensity Score Weighting Using Overlap Weights: A New Method Applied to Regorafenib Clinical Data and a Cost-Effectiveness Analysis

机译:使用重叠权重的倾向分数加权:应用于RegoraFenib临床数据的新方法和成本效益分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background: In situations of markedly different population characteristics and weak population overlap, inverse propensity score (PS) weights suffer from extreme values. The new propensity score weighting method using overlap weights (PSOW) overcomes this limitation by estimating the overlap population at the point of highest mutual overlap, thus may be preferred to other balancing methods (trimming, target, or inverse weights) in some situations.
机译:背景:在明显不同的人口特征和弱人口重叠的情况下,逆倾向得分(PS)重量遭受极值。 使用重叠权重(PSOW)的新倾倾额加权方法通过在最高互相重叠点处估计重叠群体来克服了这种限制,因此在一些情况下可能是其他平衡方法(修整,目标或逆权重)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号